MARY MORGAN: Open Payments
NPI 1104986090 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 14 payments from 12 companies in 2025. Trend: 2023 $794 · 2024 $951 · 2025 $1,882
Food & beverage: $1,266Honoraria: $600Education: $16
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $640 |
| ABIOMED | 2 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $142 |
| Incyte Corporation | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Exelixis Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $115 |
| Syndax Pharmaceuticals, Inc. | 1 | $93 |
| Geron Corporation | 1 | $83 |
Products named: COSELA, Nubeqa, Zynyz, LIBTAYO, CABOMETYX, WELIREG, RYBREVANT, REVUFORJ.
Industry payments across TX — which companies pay providers there.
